Q: What drives precision medicine at the University of Pittsburg and why is it important to meet now in Pittsburgh to focus on precision medicine advancements? A: Pittsburgh hosts the largest academic payer-provider healthcare system (UPMC and University of Pittsburgh) in the United States. Combined with...
Q: Your team was the first to show it’s possible to extract T cells from a patient, multiply them to the billions in the lab, and infuse them back into the patient to seek and destroy particular diseased cells. What is the significance of this...
I recently had a discussion with Dr. Aleks Rajkovic, Chief Genomics Officer at UCSF Health and Chair of Track 3 at PMWC Silicon Valley Jan 21-24, 2020. He shared his views on the advancements of clinical genomics implementation in the clinical setting. Find the full...
Q: In your roles as Assistant Vice Chancellor and Chief Information Officer of UCLA Health Sciences, you are responsible for the health information technology strategic plan. What emerging healthcare technologies do you anticipate will have the greatest impact on the strategic plan in the next...
PMWC sat down with Dr. Theresa LaVallee, Vice President of Translational Medicine and Regulatory Affairs at the Parker Institute for Cancer Immunotherapy, to discuss the recent developments in immunotherapy and their impact on individualized healthcare. Find the full interview on our blog post. Following are...
Q: Immunotherapy is redefining how we treat cancer. How is this treatment approach impacting healthcare and in particular individualized medicine? A: Over the last couple of decades, we have been able to improve oncology treatment for late stage cancer patients. We have been able to...
The field of precision medicine is moving forward in full speed. We are all witnessing it! Whether it is with the launch of various precision medicine/population sequencing studies, Or immunotherapy getting to be the new standard of care, and with it the potential for personally tailored treatments...
Reimbursement remains a major challenge to the widespread adoption of genomics in the clinical setting. Significant challenges remain in establishing payment for diagnostic tests that reflect the value of care, making it difficult for payers to set rates. Some of these associated issues include that...
Patient-centric data – Real-World Evidence (RWE) and Real-World Data (RWD) - are becoming increasingly instrumental in the drug development process and for making health care decisions....
The field of precision medicine is moving forward in full speed. We are all witnessing it! Whether it is with the launch of various precision medicine/population sequencing studies, Or immunotherapy getting to be the new standard of care, and with it the potential for personally tailored treatments...
